B r i e f c o m m u n i c at i o n s Action decisions are widely believed to be the product of resolving a competition between different potential action commands. Such competition has been mostly studied with eye movements (saccades) and one well-established phenomenon is the distractor effect, in which saccades to simple visual targets are delayed when an irrelevant stimulus appears elsewhere in the visual field 1 . The presence of a visual distractor is thought to automatically produce a signal in neurons of the superior colliculus and frontal eye fields (FEF) 2 and this activity competes with the activity generated by the target stimulus 3, 4 . To reach a goal-directed decision, inhibitory mechanisms are thought to suppress the distractor activity in favor of target activity 5 . Individual differences in this inhibition would strongly influence the time taken to resolve the competition and could explain fundamental differences in people's susceptibility to distraction.
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The majority of inhibitory synapses in mammals employ the neurotransmitter GABA and disrupting its normal operation in saccaderelated brain areas in monkeys disrupts eye movement control 6, 7 . However, being able to artificially disrupt a process is different to knowing what causes natural variation. We therefore examined whether the small differences in GABA concentration that naturally occur in humans help to explain basic differences in behavior.
We located the FEF individually in 12 participants using anatomical landmarks and functional magnetic resonance imaging ( Fig. 1 and Supplementary Methods) and we obtained measures of GABA concentration from a (3 cm) 3 voxel around the FEF using magnetic resonance spectroscopy (MRS) [8] [9] [10] ( Supplementary Figs. 1 and 2) . In a separate laboratory session, we assessed each participant's susceptibility to saccade distraction by measuring how much suddenly appearing distractors prolonged the time taken to initiate a saccade to a target stimulus 11 (Fig. 1d,e and Supplementary  Fig. 3 ). This varied from 5% to 36% across participants and was a stable trait (Supplementary Results).
The amplitude of the distractor effect correlated with GABA concentration measured by MRS in the region around FEF (r = −0.76, P = 0.004, 95% confidence interval, r = −0.48 to −0.91; Fig. 2a) . We confirmed this by replicating the correlation in a separate cohort of nine participants (r = −0.65, P = 0.03, one-tailed test, 95% confidence interval, r = −0.28 to −0.95; Fig. 2a and Supplementary Figs. 2 and 4) and, at the same time, ruled out any influence of the FEF localizing procedure on the MRS measure (Supplementary Methods and Supplementary Results). Notably, the correlations did not simply arise from differences in gray matter volume in the GABA voxel measured; there was no correlation between measured GABA concentration and the percentage of gray matter in the voxel in either experiment (r < 0.1) or between gray matter percentage and saccade distraction (experiment 1, r = −0.2; experiment 2, r = −0.3; overall, r = 0.03). In addition, the correlation did not arise from the age of the participants; there was no significant correlation between age and GABA concentration in our samples (r = 0.19) and the correlations between GABA concentration and saccade distraction remained strong when controlling for age (r = −0.77 and r = −0.61, respectively).
As a control, we also measured GABA in the visual cortex (Supplementary Methods). GABA concentration in the visual cortex region did not correlate at all with GABA concentration in the region around FEF (r = 0.003; Fig. 2b ). This being the case, although GABA in the frontal region predicts saccade distractibility, visual cortex GABA would not be expected to. This was indeed what we found (r = 0.3, P = 0.35; Fig. 2c) . Thus, individual differences in eye movement control appear to be attributable to differences in neurotransmitter concentration in a region that includes a brain area that is known to be a major contributor to eye movements, but not in a different region. More widely, these results indicate that GABA concentration appears to be regionally specific and suggest that it is possible to non-invasively study the relationships between neurotransmitter concentration in specific brain regions and basic behavioral variation in humans.
The exact source of the relationship we found between GABA in the frontal voxel and the resolution of competitive eye movement decisions remains undetermined. Anatomically, it is most likely to arise from the gray matter, which contains GABAergic synapses. In the gray matter, we consider the FEF to be the most likely driver of this relationship because it has been repeatedly associated with eye movement control 3, 6 , whereas the adjacent area has not, but the voxel size that we used to ensure good-quality individual MRS data precludes us from being able to state this categorically. In functional terms, it appears that higher GABA levels are associated with more efficient suppression of the influence of distractors specifically, People vary markedly in the efficiency with which they can resolve competitive action decisions, even simple ones such as shifting gaze to one stimulus rather than another. We found that an individual's ability to rapidly resolve such competition is predicted by the concentration of GABA, the main inhibitory neurotransmitter, in a region of frontal cortex that is relevant for eye movements, but not in a control region (occipital cortex).
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VOLUME 13 | NUMBER 7 | JULY 2010 nature neuroscience B r i e f c o m m u n i c at i o n s rather than more general inhibition or caution, which would also be expected to influence overall response time and error rate, neither of which correlated with GABA (r = 0.08 and r = −0.06, respectively; Supplementary Fig. 5) .
In physiological terms, naturally occurring individual differences in GABA may reflect differences in the number of GABA interneurons in certain regions, the number of synapses per neuron or simply differences in GABA concentration per synapse. Thus, we should not expect natural variation to mimic the effects of pharmacological agents, which tend to manipulate the efficacy of GABA at the synapse rather than changing the overall concentration, synapse density or cell numbers. We expect future research to clarify the relationship between natural variation and induced modulation of GABA, but we already have a hint that they are different: injections of the GABA antagonist bicuculline in monkey FEF produce greater variance in saccade latency 7 , but in our data, although some participants were more variable in their response times than others, this did not correlate with natural differences in GABA concentration (r = 0.12) Studying naturally occurring GABA differences in restricted brain regions therefore promises to offer different insights from studying the consequences of artificially manipulating GABA signaling in humans or animals.
The reasons why humans differ from each other, even in basic mechanisms of sensory-motor behavior, is crucial to our understanding of normal brain function, but it also has important implications for many clinical disorders where there appears to be a spectrum from normal to pathological without any clear boundary in between. GABAmediated inhibition (interacting with other neurotransmitters, such as dopamine) has been implicated in many such disorders, including schizophrenia, epilepsy, anxiety, depression, obsessive compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), autism and Tourette's syndrome 7, 12, 13 . Furthermore, in many of these disorders there appear to be deficits or differences in basic motor or oculomotor behavior 14 . In schizophrenia, deficits of eye movement competition and inhibition have been reliably measured over two decades 15 , which, on the basis of our current findings, we predict may correlate with regionally specific GABA concentration.
In sum, we found a link between individual variability in action control and neurotransmitter levels in a specific brain region. Moreover, our finding that GABA concentration may be regionally specific in the brain-an individual with low GABA in one brain area does not necessarily have low GABA in another area-is of crucial importance for the associations between GABA transmission and clinical disorders. 
